NCT07024615 2026-03-13
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
Astellas Pharma Inc
Phase 1 Recruiting
Clinical Trials
9 trialsNCT07199764 2026-03-06
IGNITE
University of Pennsylvania
Phase 2 Recruiting
NCT06574620 2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA Recruiting
NCT04975217 2025-11-21
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT06600906 2025-11-12
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
University of California, San Francisco
Recruiting
NCT05365893 2025-04-16
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05257993 2025-02-19
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Onconic Therapeutics Inc.
Phase 1 Recruiting
NCT06079346 2024-08-13
STOP-PC
Mateon Therapeutics
Phase 2/3 Recruiting
NCT05296421 2024-04-10
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
Phase NA Recruiting